S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NYSEARCA:LABD

Direxion Daily S&P Biotech Bear 3x Shares Stock Forecast, Price & News

$25.16
+1.86 (+7.98%)
(As of 11/26/2021 04:00 PM ET)
Add
Today's Range
$22.98
$26.19
50-Day Range
$16.90
$25.16
52-Week Range
$12.30
$36.08
Volume
2.25 million shs
Average Volume
2.86 million shs
Market Capitalization
$41.92 million
P/E Ratio
N/A
Dividend Yield
0.00%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive LABD News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Direxion
Fund NameDirexion Daily S&P Biotech Bear 3x Shares
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:LABD
Inception Date5/28/2015
Fund ManagerPaul Brigandi, Tony Ng
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkS&P Biotechnology Select Industry Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$42.16 million
Average Daily Volume$2.14 million
Discount/Premium-0.15%

ETF Expenses

Management Fee0.75%
Other Expenses0.24%
Total Expenses1.11%
Fee Waiver0.00%
Net Expenses1.07%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorRafferty Asset Management, LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market Maker

Currency Exposure of LABD













Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) Frequently Asked Questions

How has Direxion Daily S&P Biotech Bear 3x Shares' stock been impacted by Coronavirus (COVID-19)?

Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $364.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LABD shares have decreased by 93.1% and is now trading at $25.16.
View which stocks have been most impacted by COVID-19
.

When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? How did Direxion Daily S&P Biotech Bear 3x Shares' stock split work?

Shares of Direxion Daily S&P Biotech Bear 3x Shares reverse split on Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of Direxion Daily S&P Biotech Bear 3x Shares stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bear 3x Shares investors own include Direxion Daily S&P Biotech Bull 3x Shares (LABU), Micron Technology (MU), Intel (INTC), Gilead Sciences (GILD), (SNY), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Pfizer (PFE), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and ProShares UltraPro Short QQQ (SQQQ).

What is Direxion Daily S&P Biotech Bear 3x Shares' stock symbol?

Direxion Daily S&P Biotech Bear 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LABD."

Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders?

Direxion Daily S&P Biotech Bear 3x Shares' stock is owned by a variety of institutional and retail investors. Top institutional investors include Boxer Capital LLC (5.96%), Citadel Advisors LLC (0.00%), Jane Street Group LLC (0.00%), Wolverine Trading LLC (0.00%), Squarepoint Ops LLC (0.68%) and Morgan Stanley (0.25%).

Which major investors are selling Direxion Daily S&P Biotech Bear 3x Shares stock?

LABD stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG.

Which major investors are buying Direxion Daily S&P Biotech Bear 3x Shares stock?

LABD stock was purchased by a variety of institutional investors in the last quarter, including Boxer Capital LLC, Jane Street Group LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Citadel Advisors LLC, and Morgan Stanley.

How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares?

Shares of LABD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Direxion Daily S&P Biotech Bear 3x Shares' stock price today?

One share of LABD stock can currently be purchased for approximately $25.16.

How much money does Direxion Daily S&P Biotech Bear 3x Shares make?

Direxion Daily S&P Biotech Bear 3x Shares has a market capitalization of $41.92 million.


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.